Clinical Trial: Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07439445) titled 'Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication' on Feb. 20.

Brief Summary: To investigate the efficacy, safety, and compliance of a simplified strategy using vonoprazan plus clarithromycin for first-line treatment in patients with Helicobacter pylori infection, among those infected with strains without clarithromycin resistance gene mutations based on fecal clarithromycin resistance gene detection.

Study Start Date: Feb. 24

Study Type: INTERVENTIONAL

Condition: Helicobacter Pylori Infection

Intervention: DRUG: Vonoprazan 20 mg twice daily + clarithromycin 5...